PublicationPurposePublished date
Survey of fertility treatments: survey one - PCT Commissioning Managers, ABACUSTo measure implementation and impact of clinical guideline 11November 2005
Survey of fertility treatments: survey two - Fertility experts, ABACUSTo measure implementation and impact of clinical guideline 11November 2005
NICE Guidance implementation tracking, ABACUSTo track the change in utilisation of 28 technologies against expected uptakeJanuary 2005
Survey of wound care - debriding agents, ABACUSTo measure implementation and impact of technology appraisal 24August 2004
Survey of ultrasound locating devices, ABACUSTo measure implementation and impact of technology appraisal 49July 2004
Evaluation of NICE Guidance, University of York (external link)To assess the extent and pattern of implementation of 12 technology appraisals issued by NICEMarch 2004

Pharmaceutical industry reports

In addition to these commissioned evaluations, the following independent reports provide information on the use and implementation of NICE guidance:

PublicationPurposePublished date
Roche regular audits into implementation of NICE guidanceTo measure progress and track NHS use of Roche products appraised by NICEQuarterly
Implementation of NICE Guidance - An ABPI Perspective (Association of British Pharmaceutical Industries)To review change in uptake on a range of drugs appraised by NICEApril 2004

Other reports

PublicationPurposePublished date
Managing the financial implications for NICE guidance (Audit Commission)To identify best practice and make recommendations for improved financial managementSeptember 2005
Variations in usage of cancer drugs approved by NICE (National Cancer Director) (external link)To examine reported variations in usage of cancer drugs across the country, identify reasons for these variations and make recommendations to ensure all appropriate patients have access to cancer drugs approved by NICEMay 2004
NICE implementation - The patient organisation perspective(Breakthrough Breast Cancer Charity)To examine the implementation of NICE guidance on trastuzumab (Herceptin)2002